PRECLINICAL DRUG TRIALS IN THE mdx MOUSE: ASSESSMENT OF RELIABLE AND SENSITIVE OUTCOME MEASURES

The availability of animal models for Duchenne muscular dystrophy has led to extensive preclinical research on potential therapeutics. Few studies have focused on reliability and sensitivity of endpoints for mdx mouse drug trials. Therefore, we sought to compare a wide variety of reported and novel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: SPURNEY, CHRISTOPHER F., GORDISH-DRESSMAN, HEATHER, GUERRON, ALFREDO D., SALI, ARPANA, PANDEY, GOURI S., RAWAT, RASHMI, VAN DER MEULEN, JACK H., CHA, HEE-JAE, PISTILLI, EMIDIO E., PARTRIDGE, TERENCE A., HOFFMAN, ERIC P., NAGARAJU, KANNEBOYINA
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116326/
https://ncbi.nlm.nih.gov/pubmed/19260102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mus.21211
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia